RT @SBurtey: Quand on me demande pourquoi je m'intéresse à la pathologie cardio-vasculaire au cours de la maladie rénale chronique et en pa…
RT @SBurtey: Quand on me demande pourquoi je m'intéresse à la pathologie cardio-vasculaire au cours de la maladie rénale chronique et en pa…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
【ESRDの若年成人ではCV死亡リスクが著増 / JAMA】 米国全国データ、1-29歳で腎代替療法開始の33156例解析:観察開始時22-29歳だった20245例の死亡に占めるCV死亡の割合は39.1%。健常対照に比べCV死亡リスクは143-500高値となる計算。 https://t.co/H3G0vXGpyE [Free] https://t.co/etOJgJIBuj
RT @SBurtey: Quand on me demande pourquoi je m'intéresse à la pathologie cardio-vasculaire au cours de la maladie rénale chronique et en pa…
Quand on me demande pourquoi je m'intéresse à la pathologie cardio-vasculaire au cours de la maladie rénale chronique et en particulier aux toxines uremiques. Je regarde ces chiffres de mortalité chez le 22-29 ans et je sais. https://t.co/4iczGSaeOF
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @zjmodi: Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease. https://t.co/vL…
RT @zjmodi: Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease. https://t.co/vL…
RT @NHLBI_Translate: .@NIH-funded research shows that #CardiovascularDisease accounted for ~40% of deaths in young adults w/ new #ESRD. Ide…
RT @zjmodi: Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease. https://t.co/vL…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @zjmodi: Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease. https://t.co/vL…
RT @zjmodi: Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease. https://t.co/vL…
RT @NHLBI_Translate: .@NIH-funded research shows that #CardiovascularDisease accounted for ~40% of deaths in young adults w/ new #ESRD. Ide…
RT @NHLBI_Translate: .@NIH-funded research shows that #CardiovascularDisease accounted for ~40% of deaths in young adults w/ new #ESRD. Ide…
.@NIH-funded research shows that #CardiovascularDisease accounted for ~40% of deaths in young adults w/ new #ESRD. Identified #risk factors may inform development of age-appropriate strategies to improve cardiovascular health of this population. @NIH_NHLBI
RT @zjmodi: Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease. https://t.co/vL…
RT @zjmodi: Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease. https://t.co/vL…
RT @zjmodi: Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease. https://t.co/vL…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @zjmodi: Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease. https://t.co/vL…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @JAMACardio: Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from bot…
RT @zjmodi: Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease. https://t.co/vL…
Excited to share our work looking at the cardiovascular outcomes of young-adults with end-stage #KidneyDisease.
Published today - research from CHEAR Faculty @zjmodi in JAMA Cardiology: Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease https://t.co/ILHBhWX2Dg
Young adults with end-stage #renaldisease have high cardiovascular a morbidity and mortality burden and are unique from both children and older adults https://t.co/y6Xdtx4pZA